ADHD medication shortages in the UK have been ongoing since late 2023, with Elvanse (lisdexamfetamine) and multiple methylphenidate brands intermittently unavailable. The shortage has left many adults and children unable to access their prescribed ADHD treatment.
Current Active Shortages (2)
Lisdexamfetamine (Elvanse®) capsules
Active DHSC MSNDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Lisdexamfetamine (Elvanse®) capsules. • There will be intermittent supply of all strengths of lisdexamfetamine
Lisdexamfetamine (Elvanse®) capsules
Active DHSC MSNDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Lisdexamfetamine (Elvanse®) capsules • All strengths of Elvanse® capsules are now available and an improved le
What to Do If Affected
- Contact your ADHD clinic or psychiatrist immediately if you can't get your medication
- Don't stop ADHD medication abruptly without medical advice
- Ask your pharmacist to check alternative brands of methylphenidate
- Non-stimulant alternatives like atomoxetine may be available
- Contact ADHD UK for support: adhduk.co.uk
Related Medicine Pages
Don't get caught off guard
Join 5,000+ patients getting early warning — 3 medicines went into shortage this week
Join free alerts →
Data sources: DHSC Medicine Supply Notifications · NHSBSA Serious Shortage Protocols · NHS England
Page last updated: 13 May 2026. Data checked daily.
Page last updated: 13 May 2026. Data checked daily.